Azelis has agreed to acquire 100% of the shares of Agspec Australia, a leading distributor of crop nutrition, crop protection and specialty agricultural products in Australia. Financial terms of the transaction, which is expected to close in the first quarter of 2024 and is subject to customary closing conditions, were not disclosed.
Olon, an Italian CDMO and API producer of active pharmaceutical ingredients (APIs), plans to invest €10 million in a multi-year expansion of its production site in Mahad, India.
Arkema board of directors has unanimously expressed its confidence in the company’s chairman and CEO Thierry Le Hénaff to execute the strategy announced during Arkema’s capital markets day on Sep. 27 and proposed the renewal of his term of office for four years at the company’s next annual shareholders meeting in May 2024.
Serbian agrochemicals producer Elixir Group and German minerals producer K+S have signed a cooperation agreement for the production and distribution of crystalline water-soluble fertilizer mono-ammonium phosphate (MAP).
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a major revision of pharmaceutical regulations as proposed by the European Commission in April this year could shrink Europe's share of global research and development by a third to 21% by 2040, resulting in a loss of investment of €2 billion ($2.15 billion) a year.
Air Products unveiled plans for a carbon capture facility at its Rotterdam plant, intending to generate "blue" hydrogen for ExxonMobil's refinery and other clients. Anticipated to become Europe's largest upon its scheduled completion in 2026, this initiative will play a pivotal role in substantially reducing carbon dioxide emissions in Rotterdam, aligning with the Dutch climate objectives.
Noramco, a US producer of active pharmaceutical ingredients (APIs), has completed the acquisition of the Cambrex drug product business unit previously known as Halo Pharmaceuticals. Financial details were not disclosed.
DKSH has signed an agreement to acquire 100% of Bio-Strategy, said to be the largest independent distributor of scientific instruments in Australia and New Zealand, with a focus primarily on life sciences, medical & healthcare and environment & agriculture.
US specialty chemical company Milliken is rebranding its healthcare business Milliken Healthcare Products to Ovik Health.
US specialty chemicals producer Ashland has announced that it will start a divestiture process for the company’s nutraceuticals business.
Solvay announced the future executive leadership team, effective upon completion of the planned separation of Solvay into two companies – Solvay and Syensqo – which is expected to be completed in December.
DMC Biotechnologies announced a new 880 square meter (9,500 square foot) metabolic engineering and fermentation facility in North Carolina, to support a team of scientists advancing DMC products and active collaborations.
Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the development of therapeutics across oncology, immunology and rare diseases.
Asahi Kasei will invest in new coating equipment for Hipore lithium-ion battery separators in its US, Japan, and South Korea facilities, starting in the first half of fiscal year 2026. The increased capacity will provide coated separators for batteries powering up to 1.7 million electric vehicles.
The Ghanian start-up Aquamet provides a sustainable and affordable solution to maximize fish farmers´ yield.
Aragen, an India, Hyderabad-headquartered contract research development and manufacturing organization (CRDMO) for small molecules and biologics, plans to set up a new biologics manufacturing facility in Bangalore, India.
Nouryon launched full-scale production at its new Expancel expandable microspheres plant in Green Bay, Wisconsin, USA, enhancing service for specialty additives customers in North America across various industries. This complements existing facilities in Sweden, China, and Brazil.
Clariant today announced that it has agreed to acquire Lucas Meyer Cosmetics, a provider of high-value ingredients for the cosmetics and personal care industry, from International Flavors & Fragrances (IFF) for a total cash consideration of €765 million ($810 million).
CEFIC, the European Chemical Industry Council, together with other associations representing Europe’s clean technology industries and their key material suppliers, sent a joint letter to European Commission president Ursula von der Leyen ahead of last week’s European Council summit. They jointly expressed their support of von der Leyen's commitment that "the future of our clean tech industry must be made in Europe.”
LyondellBasell has acquired a 25% stake in Cyclyx International, a joint venture between Agilyx and ExxonMobil formed in December 2020. Cyclyx is working with industry participants to develop innovative recycling solutions for all types of post-use plastics and aims at increasing the recyclability of plastics from 10% to 90%.
Arkema starts Sartomer UV/LED resin production at its Nansha, China facility, doubling capacity to fuel sustainable solutions for emerging Asian markets like advanced electronics and renewable energies.
Carbios announces that it has been granted the building permit and operating authorization for the world’s first polyethylene terephthalate (PET) biorecycling plant, allowing construction to start.
Samsung Biologics, a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture capital firm in healthcare and biotechnology, recently announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ portfolio companies.
Toray Advanced Materials Korea Inc. (TAK), the South Korean subsidiary of Japanese chemical giant Toray Group, broke ground on its new facility for carbon fiber production in Gumi, Korea.
EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane Monges, the current Board Chair, as interim CEO until a permanent successor is found, while she continues her role as Board Chair.
Sasol Chemicals, a division of Sasol Ltd., and Solugen have unveiled a partnership to investigate the development of innovative solutions to address the increasing consumer need for eco-friendly ingredients in household and personal care items.
Quotient Sciences, a drug development and manufacturing accelerator, has invested significantly in expanding its sterile fill/finish capabilities at its Alnwick, UK facility. This expansion aims to meet the rising demand in the industry for comprehensive drug development programs by enhancing the capacity of the Annex 1-compliant facility.
The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing questions, with their answers informing the industry landscape for the next year, spanning all major pharma markets.
Nanoform, a nanoparticle medical technology company, has awarded AstraZeneca a global online STARMAP license. STARMAP is an AI-based digital rendition of CESS technology, facilitating in-silico experiments for selecting molecules to be nanoformed. This license enables AstraZeneca to screen molecules during the entire drug development process.
The Board of Directors at Syngenta Group has appointed Hengde Qin as the new Chief Financial Officer, starting from December 1, 2023. Qin will take over from Chen Lichtenstein who has served as CFO since Syngenta Group's inception but is now leaving to explore other business ventures.
Fluor Corporation announced today that it has completed construction of Bayer’s first global Cell Therapy Launch Facility in Berkeley, California. Completion was celebrated on October 10, 2023, at the new facility with local officials, dignitaries, Bayer employees, and clients.
Jeff Rowe will become Syngenta Group's CEO on January 1, 2024, transitioning from his current role as President of Syngenta Crop Protection. The current CEO, Erik Fyrwald, will retire at the end of the year after almost seven and a half years with the company. After retiring, Fyrwald will act as an Advisor to the Chairman of Syngenta Group and retain his position on the Board of Directors.
Daiichi Sankyo and Merck & Co. to co-develop and commercialize three of Daiichi Sankyo’s DXd antibody-drug conjugate (ADC) candidates worldwide except for Japan where Daiichi Sankyo retains exclusive rights. Merck to pay Daiichi Sankyo up to €20.8 billion for the collaboration.
The US pharmaceutical company Pfizer has been cleared to acquire Seagen, a biotech company focused on developing cancer treatments.
Brazilian chemical group Unipar Carbocloro will modernize its chlor-alkali plant in Cubatão, Brazil, with electrolyzer technology from Dortmund, Germany-headquartered Thyssenkrupp Nucera. The upgrade is scheduled to be completed by the end of 2025. According to Thyssenkrupp, Unipar will invest more than 1 billion reais (about €190 million) in the modernization.
